FNDC5 and atherosclerosis: Similarly, serum irisin concentrations were lower in diabetic patients with concomitant atherosclerosis than in diabetic patients without atherosclerosis, suggesting that circulating irisin has the potential to be used as a diagnostic biomarker for monitoring the progression of CVD in diabetic patients [135,136].